OOIR: Observatory of International Research

Papers

(The H4-Index of Diabetic Medicine is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus	77
Bone marrow stromal cell‐derived exosomal circular RNA improves diabetic foot ulcer wound healing by activating the nuclear factor erythroid 2‐related factor 2 pathway and inhibiting ferroptosis	71
The management of diabetic ketoacidosis in adults—An updated guideline from the Joint British Diabetes Society for Inpatient Care	59
The SARS‐CoV‐2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: A multi‐centre study of the first COVID‐19 wave	48
Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta‐analysis of randomised controlled trials	46
The impact of the COVID‐19 pandemic on people with diabetes and diabetes services: A pan‐European survey of diabetes specialist nurses undertaken by the Foundation of European Nurses in Diabetes surve	45
The bidirectional longitudinal association between depressive symptoms and HbA_1c: A systematic review and meta‐analysis	38
International comparison of glycaemic control in people with type 1 diabetes: an update and extension	38
Real‐world evidence on clinical outcomes of people with type 1 diabetes using open‐source and commercial automated insulin dosing systems: A systematic review	38
Effects of mindfulness‐ and acceptance‐based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta‐analysis	37
Acute hyperglycaemic crisis after vaccination against COVID‐19: A case series	36
Impact of the COVID‐19 pandemic and lockdown restrictions on psychosocial and behavioural outcomes among Australian adults with type 2 diabetes: Findings from the PREDICT cohort study	35
Developmental programming by maternal obesity: Lessons from animal models	34
Sustained type 1 diabetes self‐management: Specifying the behaviours involved and their influences	33
Time in range: A best practice guide for UK diabetes healthcare professionals in the context of the COVID‐19 global pandemic	33
Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: Beyond glycated haemoglobin	32
Impact of routine clinic measurement of serum C‐peptide in people with a clinician‐diagnosis of type 1 diabetes	30
Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta‐analysis of randomized clinical trials	29
Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation	29
UCMSCs‐derived exosomal circHIPK3 promotes ulcer wound angiogenesis of diabetes mellitus via miR‐20b‐5p/Nrf2/VEGFA axis	29
The impact of COVID‐19 restrictions on accelerometer‐assessed physical activity and sleep in individuals with type 2 diabetes	28
Real world use of hybrid‐closed loop in children and young people with type 1 diabetes mellitus—a National Health Service pilot initiative in England	28
Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review	27
A systematic review of illness perception interventions in type 2 diabetes: Effects on glycaemic control and illness perceptions	27
An overview of COVID‐19 in people with diabetes: Pathophysiology and considerations in the inpatient setting	26

Living with diabetes alongside a severe mental illness: A qualitative exploration with people with severe mental illness, family members and healthcare staff